GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status

Clinical Biochemistry

Volumn 48, Issue 12, 2015, Pages 811-814

  Dullaart, Robin P F ^a   Gruppen, Eke G ^a   Connelly, Margery A ^b   Otvos, James D ^b   Lefrandt, Joop D ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

C reactive protein; Diabetes mellitus; Glycoproteins; Leptin adiponectin ratio; Nuclear magnetic resonance spectroscopy

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; GLYCA PROTEIN; LEPTIN; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; GLYCOPROTEIN;

ADULT; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; BLOOD; CASE CONTROL STUDY; GLYCOSYLATION; INFLAMMATION; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE; STATISTICAL MODEL;

ADIPONECTIN; BIOMARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; INFLAMMATION; LEPTIN; LINEAR MODELS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 84938201305     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.05.001     Document Type: Article

References (15)

1. Gornik O., Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers 2008, 25:267-278.
2. Otvos J., Shalaurova I., Wolak-Dinsmore J., Connelly M.A., Mackey R.H., Stein J.H., et al. GlycA: a nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem 2015, 61:14-23.
3. Akinkuolie A.O., Buring J.E., Ridker P.M., Mora S. A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc Sep 23 2014, 3(5). [pii: e001221]. 10.1161/JAHA.114.001221.
4. Akinkuolie A.O., Pradhan A.D., Buring J.E., Ridker P.M., Mora S. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol Apr 23 2015, [pii: ATVBAHA.115.305635. Epub ahead of print].
5. Arnold J.N., Saldova R., Hamid U.M., Rudd P.M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8:3284-3293.
6. Dallinga-Thie G.M., Dullaart R.P.F. Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations?. Atherosclerosis 2010, 208:328-329.
7. Blüher M., Mantzoros C.S. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 2015, 64:131-145.
8. Finucane F.M., Luan J., Wareham N.J., Sharp S.J., O'Rahilly S., Balkau B., et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009, 52:2345-2349.
9. Dullaart R.P., Kappelle P.J., Dallinga-Thie G.M. Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study. Atherosclerosis 2010, 211:393-396.
10. Karakas M., Zierer A., Herder C., Baumert J., Meisinger C., Koenig W., et al. Leptin, adiponectin, their ratio and risk of coronary heart disease: results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 2010, 209:220-225.
11. Kappelle P.J., Dullaart R.P.F., van Beek A.P., Hillege H.L., Wolffenbuttel B.H.R. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study. Eur J Intern Med 2012, 23:755-759.
12. Jeyarajah E.J., Cromwell W.C., Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006, 26:847-870.
13. Dullaart R.P.F., de Vries R., van Tol A., Sluiter W.J. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol 2007, 156:387-394.
14. Fischer K., Kettunen J., Würtz P., Haller T., Havulinna A.S., Kangas A.J., et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med 2014, 11:e1001606.
15. Emoto M., Nishizawa Y., Maekawa K., Hiura Y., Kanda H., Kawagishi T., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999, 22:818-822.